PROSPECTUS
Dated: December 16, 2021

Please read Section 32 of the Companies Act, 2013
Book Built Offer

MedPlus

MEDPLUS HEALTH SERVICES LIMITED

Our Company was incorporated as ‘MedPlus Health Services Private Limited’ at Hyderabad, Andhra Pradesh as a private limited company under the Companies Act, 1956, and was
granted the certificate of incorporation on November 30, 2006 by the Registrar of Companies, Andhra Pradesh at Hyderabad. Our Company was converted from a private limited
company to a public limited company, pursuant to a special resolution passed by our Shareholders at the extraordinary general meeting held on June 1, 2021 and the name of our
Company was changed to ‘MedPlus Health Services Limited’. Consequently, a fresh certificate of incorporation was issued by the Registrar of Companies, Telangana at Hyderabad
(“RoC”) on June 28, 2021, For further details see, “History and Certain Corporate Matters” on page 169.
Registered Office: 707, 7th Floor, 5-9-13, Taramandal Commercial Complex, Saifabad, Hyderabad 500 004, Telangana, India; Tel: +91 040 6724 6724;
Corporate Office: Municipal No: 11-6-56, Survey No. 257 & 258/1, C Block, III Floor, Opp: Railway Siding (Moosapet), Kukatpally, Hyderabad 500 037, Telangana, India; Te
+91 040 6724 6724;
Website: www.medplusindia.com; Contact Person: Parag Jain, Company Secretary and Compliance Officer; E-mail: cs@medplusindia.com;
Corporate Identity Number: U85110TG2006PLC051845
FST OOTP NE NTO AMON SNP TO UNA TE TEPC DO

INITIAL PUBLIC OFFERING OF 17,573,342 EQUITY SHARES OF FACE VALUE OF &2 EACH (EQUITY SHARES") OF MEDPLUS HEALTH SERVICES LIMITED (OUR “COMPANY” OR THE,

COMPANY” OR THE “ISSUER") FOR CASH AT A PRICE OF #796 PER EQUITY SHARE (INCLUDING A PREMIUM OF 2794 PER EQUITY SHARE) (“OFFER PRICE") AGGREGATING TO €13,982.95,
MILLION (THE “OFFER"), COMPRISING OF A FRESH ISSUE OF 7,544,511 EQUITY SHARES AGGREGATING TO %6,000 MILLION (THE “FRESH ISSUE") BY OUR COMPANY AND AN OFFER FOR
SALE OF 10,026,831 EQUITY SHARES AGGREGATING TO 7,982.95 MILLION (THE “OFFER FOR SALE"), COMPRISING OF 7,826,626 EQUITY SHARES AGGREGATING TO 6,230 MILLION BY PI
OPPORTUNITIES FUND ~ I (INVESTOR SELLING SHAREHOLDER"), 1344221 EQUITY SHARES AGGREGATING TO 1,070.00 MILLION BY S. S. PHARMA LLC, 402,010 EQUITY SHARES
AGGREGATING TO %20.00 MILLION BY SHORE PHARMA LLC, 125,628 EQUITY SHARES AGGREGATING TO £100.00 MILLION BY NATCO PHARMA LIMITED, 125,628 EQUITY SHARES
AGGREGATING TO 2100.00 MILLION BY TIME CAP PHARMA LABS PRIVATE LIMITED, 89,547 EQUITY SHARES AGGREGATING TO €7128 MILLION BY A. RAGHAVA REDDY, 53,115 EQUITY
SHARES AGGREGATING TO £42.28 MILLION BY K PRAKURTHI, 27,135 EQUITY SHARES AGGREGATING TO 221.60 MILLION BY NAVDEEP PATYAL, 18,467 EQUITY SHARES AGGREGATING TO
414.70 MILLION BY SANGEETA RAJU, 14,974 EQUITY SHARES AGGREGATING TO &11.92 MILLION BY R. VENKAT REDDY, 276 EQUITY SHARES AGGREGATING TO @ 0.22 MILLION BY TK
KURIEN, 251 EQUITY SHARES AGGREGATING 10 £0.20 MILLION BY NITHY A VENKATARAMANI, 251 EQUITY SHARES AGGREGATING TO 0.20 MILLION BY ATUL GUPTA, 251 EQUITY SHARES
AGGREGATING TO %0.20 MILLION BY MANOJ JAISWAL, 251 EQUITY SHARES AGGREGATING TO £0.20 MILLION BY RAHUL GARG, 100 EQUITY SHARES AGGREGATING TO £0.08 MILLION
BY KOLLENGODE RAMANATHAN LAKSHMINARAYANA AND 100 EQUITY SHARES AGGREGATING TO £0.08 MILLION BY BIJOU KURIEN (COLLECTIVELY, THE “OTHER SELLING
SHAREHOLDERS" AND COLLECTIVELY WITH THE INVESTOR SELLING SHAREHOLDER ARE REFERRED TO AS THE “SELLING SHAREHOLDERS") AND SUCH EQUITY SHARES, THE
“OFFERED SHARES").
‘THE OFFER INCLUDES A RESERVATION OF 69,637 EQUITY SHARES, AGGREGATING UP TO %50 MILLION (CONSTITUTING UP TO 0.06% OF THE POST-OFFER PAID-UP EQUITY SHARE
CAPITAL), FOR SUBSCRIPTION BY ELIGIBLE EMPLOYEES (AS DEFINED HEREINAFTER) (“EMPLOYEE RESERVATION PORTION"). THE OFFER LESS THE EMPLOYEE RESERVATION PORTION
1S HEREINAFTER REFERRED TO AS THE “NET OFFER". OUR COMPANY AND THE INVESTOR SELLING SHAREHOLDER MAY, IN CONSULTATION WITH THE BOOK RUNNING LEAD
MANAGERS, OFFER A DISCOUNT OF 9.80 TO THE OFFER PRICE TO ELIGIBLE EMPLOYEES BIDDING IN THE EMPLOYEE RESERVATION PORTION (“EMPLOYEE DISCOUNT").
‘THE OFFER AND THE NET OFFER SHALL CONSTITUTE 14.72% AND 14.67%, RESPECTIVELY, OF THE POST-OFFER PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY").
THE FACE VALUE OF EQUITY SHARES IS #2 EACH, THE. OFFER PRICE IS 398 TIMES THE FACE VALUE OF THE EQUITY SHARES.
"SUBJECT TO FINALISATION OF THE BASIS OF ALLOTMENT.
“4 DISCOUNT OF #78 PER EQUITY SHARE WAS OFFERED TO ELIGIBLE EMPLOYEES BIDDING

 

 

  

 

    

    

 

 

 

 

    

 

IN THE EMPLOYEE RESERVATION PORTION.

 

‘The Offer was made through the Book Building Process, in terms of Rule 19(2\(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRRC) read with Regulation 3 of the Securities and Exchange Board of
India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the “SEBI [CDR Regulations”). This Offer isin compliance with Regulation 6(1) ofthe SEBI ICDR Regulations wherein not more than
50% of the Net Ofer was made available far allocation on a proportionate basis to Qualified Institutional Buyers (“QUBS" and such portion the “QIB Portion") provided that our Company and the Investor Selling Shareholder,
in consultation with the BRLMSs, allocated 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (“Anchor Investor Portion”), of which one-third was reserved
for domestic Mutual Funds, subject to valid Bids having been received from domestic Mutual Funds ator above the Anchor Investor Allocation Price, in accordance with the SEBI ICDR Regulations, Further, 5% ofthe Net QL
Portion was made available for allocation on a proportionate basis to Mutual Funds only and the remainder of the Net QUB Portion was made available fr allocation on a proportionate basis to all QIBSs (other than Anchor
Investors) including Mutual Funds, subject to valid Bids having been received ator above the Offer Price. However, ifthe aggregate demand from Mutual Funds is less than 5% of the Net QIB Porton, the balance Equity Shares
was made available for allocation in the Mutual Fund Portion were added to the remaining QUB Portion for proportionate allocation to QUBS. Further, not less than 15% of the Net Offer was made available for allocation on a
proportionate basis to Non-Institutional Bidders and not less than 35% ofthe Net Offer was made available for allocation to Retail Individyal Bidders ("RIB") in accordance with the SEBI ICDR Regulations, subject to valid
Bids being received from them at or above the Offer Price, Further, 69,637 Equity Shares aggregating to &50 million will be avalable for allocation to Eligible Employees, subject to valid Bids being received at or above the
(Offer Price. All Bidders (except Anchor Investors) were required to mandatorly utilise the Application Supported by Blocked Amount (“ASBA") process by providing details of thelr respective ASBA accounts and UPL ID (in
‘ase of RIBS using the UPI Mechanism), in which case the corresponding Bid Amounts were blocked by the SCSBs or under the UPI Mechanism, as applicable to participate inthe Offer. Anchor Investors were not permitted to

ee

"Tis being the fst public ssue of our Company, ere hasbeen no formal market for the Equty Shares of out Company. The face Value of the Equity Shares is 2. The Floor Pic, Cap Price and Ofer Price should not be aken tobe indicave ofthe
markt price ofthe Equity Shares after the Equity Shares are listed No assurance can be given regarding active andor sustained radg in the Equity Shares nor regarding the price at which the Equity Shares wil be waded atte isting
Eas
Tnvesument in equity and equty-rlated secures involve a degre of risk and investors should not invest any funds inthe Ofer unless they can alford to lake the Fisk of losing thelr ene investment Investors ae advised to fead the isk factors
‘aefully before taking an investment decision inthe Ole. For taking an investment decision, investors must rely on ter wen examination of our Company and the Offer, including the rise involved. The Equity Sires in the Offer have not been
recommended or approved bythe Secrties and Exchange Hoard of India ("SEBI), nor does SEBI guarantee the accuracy or acequacy ofthe contents ofthis Prospects, Specific attention of th investors iim to "Rsk Factors” on page 29.
CSOT SES ESTA OT SRC TON
‘Our Company, having made al reasonable inquiries, accepts responsiblity for and confms hat this Prospecs contains all information wih regard to our Company and the Offer, which s material nthe context of the Oder, thatthe information
contained in this Prospeews is tre and correc in all material aspects and s not misleading in any material respect, tht opinions and itetions expressed herein are honesty held and tht there are no other facts, the omission of which makes this
Prospects asa whole ar any of such information or the expression of any such opinions or intentions misleading in any material respect. Each ofthe Selling Shareholders, severally and not jointly acept responsibility for and confirms the statements
specifically made or confirmed by such Selling Shareholder in this Prospectus tothe extent of information specifically peaining to such Selling Shareholder and is respective portio ofthe Offered Shares and assumes responsibility that such
‘Satements are true and correct inall material respects an ot misleading in any material respect. Each Selling Shareholder severally and not jointly, assumes no responsiblity for any other statement in this Prospects, including, iter alia, any ofthe
Statements made by or relating 10 our Company or its business or anyother Selling Shareholders

 

   

   

 

 

 

LISTING,
"The Equity Shares tobe Aljoted through the Red Herring Prospectus and his Prospectus are proposed tobe listed on te Siock Exchanges. Our Company has received impanciple” approvals tram BSE and NSE forthe

 

 

ing of tbe Eguity Shares

pursuant to ther leers dated September 2, 2021 and September 1, 202, respectively. For the purposes of the Offer, the Designated Stock Exchange is BSE. signed copy ofthe Red Herring Prospectus hasbeen and this Prospects shal be delivered
{othe RoC inaccordance with Sections 26(8) and 2 ofthe Companies Act, 2013. Fr details ofthe material contacts and dacuments which were made available for inspection frm te date ofthe Red Herring Prospectus upto the Bid Ofer Closing,
Date, se "Moterial Contracts and Document for Inspection” on page 63,

 

 

 

 

 

 

 

 

a See

perrsconrat Anis Ww yee NOAURA MFINTECH

REDIT SUISSE Se
ak Eee Cal ar Sea Gay PR Babs ess nied —| Hopes me hia mes — its ea
Sa Sel Se nea jai ecteer Saree
Ceri lity, | Exe Godly Sm Soe SS ee ancien [Seer eee
oy eae ce one ci ea eee ed
WO ia erect =o erm von
eno es erry eagoat ee ar sanca ami
ae ee ace eee icdniaam [Rented as oe sr
TI aaa ee: | coon ee ee cc =e
a en iam, [Ee eee ea Slee, | tenement
See ee aca once —— eee
ee races. | eee = SS le
eo Se ee iaas | We acrapacicmagpat'| Sm aboTae es miee that
See, | eerie ore
Sea ceaer orbi Se asagatreniaia

‘SEBI Registration No: INMO0001 1419.

 

 

 

BID/ OFFER OPENED ON. ‘Monday, December 13,2021" BID/ OFFER CLOSED ON. ‘Wednesday, December 15,2021

 

“The Anchor Invesior Bid Offer Period was one Working Day prior tothe Bid/ Offer Opening Date Le, December 10, 2021
